Skip to Main Content

Paper Details

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.
J Acquir Immune Defic Syndr Hum Retrovirol
39
1996

Datasets

Release 1.2